It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Genome-wide association studies implicate multiple loci in risk for systemic lupus erythematosus (SLE), but few contain exonic variants, rendering systematic identification of non-coding variants essential to decoding SLE genetics. We utilized SNP-seq and bioinformatic enrichment to interrogate 2180 single-nucleotide polymorphisms (SNPs) from 87 SLE risk loci for potential binding of transcription factors and related proteins from B cells. 52 SNPs that passed initial screening were tested by electrophoretic mobility shift and luciferase reporter assays. To validate the approach, we studied rs2297550 in detail, finding that the risk allele enhanced binding to the transcription factor Ikaros (encoded by IKZF1), thereby modulating expression of IKBKE. Correspondingly, primary cells from genotyped healthy donors bearing the risk allele expressed higher levels of the interferon / NF-κB regulator IKKε. Together, these findings define a set of likely functional non-coding lupus risk variants and identify a regulatory pathway involving rs2297550, Ikaros, and IKKε implicated by human genetics in risk for SLE.
Here, the authors use SNP-seq to screen 87 lupus risk loci for functional non-coding variants. Validation at one locus identified a risk variant through which enhanced Ikaros binding amplifies expression of the interferon / NFκB regulator IKKε.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Harvard Medical School, Division of Immunology, Boston Children’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
2 Harvard Medical School, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Instituto de Investigación Sanitaria Gregorio Marañón, Laboratory of Immune-regulation, Madrid, Spain (GRID:grid.410526.4) (ISNI:0000 0001 0277 7938)
3 Harvard Medical School, Division of Immunology, Boston Children’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
4 Harvard Medical School, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
5 Cincinnati Children’s Hospital Medical Center, Center of Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)
6 Wake Forest University School of Medicine, Department of Biostatistics and Data Science, Winston-Salem, USA (GRID:grid.241167.7) (ISNI:0000 0001 2185 3318); Wake Forest University School of Medicine, Center for Precision Medicine, Winston-Salem, USA (GRID:grid.241167.7) (ISNI:0000 0001 2185 3318)
7 Cincinnati Children’s Hospital Medical Center, Center of Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); Cincinnati Children’s Hospital Medical Center, Divisions of Human Genetics, Biomedical Informatics, and Developmental Biology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); Cincinnati, Department of Pediatrics, University of Cincinnati College of Medicine, Ohio, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593)
8 Harvard Medical School, Division of Immunology, Boston Children’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard Medical School, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)